During National Kidney Month, Fresenius Medical Care Calls Attention to High Blood Pressure as a Leading Cause of Kidney Dise...
March 14 2013 - 8:00AM
Business Wire
With high blood pressure now the second most common cause of
chronic kidney disease (CKD) in the United States (behind only
diabetes), Fresenius Medical Care North America (FMCNA) wants
people to know that controlling their blood pressure can slow the
progression of CKD, and help prevent heart disease and strokes in
those who are on dialysis.
This March during National Kidney Month, FMCNA, the nation’s
leading network of dialysis facilities, is raising awareness about
the widespread problem of high blood pressure, or hypertension,
especially if left untreated. FMCNA also is calling attention to
the benefits of healthy eating and physical activity for dialysis
patients and those with hypertension by sponsoring a tour by Chef
Aaron McCargo, Jr. and his kidney-friendly “flavor of bold”
recipes. For more information about FMCNA’s National Kidney Month
recipes and activities, visit
www.ultracare-dialysis.com/kidneymonth.
High blood pressure affects nearly one in three Americans,
although many people don’t realize they have it because of its lack
of signs or symptoms. Typically the result of hardened blood
vessels or too much fluid in the blood, high blood pressure causes
the heart to work harder. Over time, it increases the risk of heart
disease and stroke and can damage blood vessels throughout the
body, including those used by the kidneys to remove waste and extra
fluid. The resulting kidney damage can lead to CKD and eventually
kidney failure, which may be treated with renal transplant or
dialysis.
“Every year high blood pressure causes more than 32,000 new U.S.
cases of kidney failure,” says Dr. Dugan W. Maddux, vice president
of chronic kidney disease initiatives at FMCNA. “Fortunately, high
blood pressure can be treated through medication, nutrition,
physical activity and lifestyle changes. Awareness is critical if
we are to reduce kidney failure due to hypertension.”
Tips for Dialysis Patients with High Blood
Pressure
FMCNA recommends that people have their blood pressure tested.
Dialysis patients with high blood pressure should work with their
doctor and dialysis care team to develop a treatment plan, which
may include:
• Consuming less sodium (salt).
• Eating renal-friendly meals high in protein, and low in sugar,
potassium and phosphorus.
• Exercising for 30 minutes or more at least three times a
week.
• Quitting smoking, if you are a smoker.
• Losing weight, if you are overweight.
• Taking blood pressure medication, if prescribed.
Dialysis is a life-sustaining process that cleans waste products
and removes extra fluids from a person’s blood when CKD leads to
kidney failure. For more information about dialysis facilities near
you, call toll free at 1-888-325-5175.
FMCNA is helping dialysis patients achieve better health
outcomes through initiatives such as its “Strong Bones, Healthy
Heart” program. It aims to improve patients’ bone and mineral
metabolism, as well as blood pressure levels, by encouraging them
to actively participate in developing and following meal,
medication and treatment plans in close coordination with their
families, physicians and dialysis staff.
About Fresenius Medical Care North AmericaThrough our
leading network of more than 2,100 dialysis facilities in North
America and our vascular access centers, laboratory, pharmacy and
affiliated hospitals and nephrology practices, Fresenius Medical
Care provides renal services to hundreds of thousands of people
throughout the United States, Mexico and Canada. We are also the
continent’s top producer of dialysis equipment, dialyzers and
related disposable products and a major supplier of renal
pharmaceuticals.
For more information about the company, visit www.fmcna.com; for
information about patient services, visit
www.ultracare-dialysis.com.
Fresenius Medical Care (TG:FME)
Historical Stock Chart
From Jan 2025 to Feb 2025
Fresenius Medical Care (TG:FME)
Historical Stock Chart
From Feb 2024 to Feb 2025